The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Vitiello, B.
* Articles by Shapiro, M. F.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Vitiello, B.
* Articles by Shapiro, M. F.
Related Collections
* AIDS/HIV
* Other Somatic Therapy
Am J Psychiatry 160:547-554, March 2003
© 2003 American Psychiatric Association


Article

Use of Psychotropic Medications Among HIV-Infected Patients in the United States

Benedetto Vitiello, M.D., M. Audrey Burnam, Ph.D., Eric G. Bing, M.D., Ph.D., M.P.H., Robin Beckman, M.P.H., and Martin F. Shapiro, M.D., Ph.D.

OBJECTIVE: This study describes the prevalence and pattern of use of psychotropic medications by HIV-positive patients receiving medical care in the United States and the search for possible predictors of use. METHOD: The HIV Cost and Services Utilization Study database was analyzed. From the estimated 231,400 HIV-positive patients in medical care in the contiguous United States, a probability sample of 2,864 adults who had paid at least one visit to their medical provider in early 1996 was selected. A representative group of 1,561 received the long form of the Composite International Diagnostic Interview and a questionnaire on psychotropic medications used during the previous 6 months; 1,489 patients (95.4%) completed the assessments. RESULTS: An estimated 27.2% of HIV-positive patients took psychotropic medications in 1996. Antidepressants were the most commonly prescribed drug class (20.9% of patients), followed by anxiolytics (16.7%), antipsychotics (4.7%), and psychostimulants (3.0%). Among patients with major depression or dysthymia, 43.2% reported receiving antidepressants, and 34.3% reported receiving anxiolytics. Psychiatric comorbidity was associated with greater use of psychotropics. Use of psychotropics in general, and antidepressants in particular, was significantly lower among African Americans than whites or Hispanics. Among patients with mood disorders, 61.0% of whites, 51.4% of African Americans, and 66.7% of Hispanics reported use of antidepressant medications or some type of psychosocial intervention. CONCLUSIONS: Psychotropics were commonly used by HIV-positive patients in medical care. About half of the patients suffering from depressive disorders did not receive antidepressants. Psychotropic drug use was lower among African Americans than other ethnic groups.




This article has been cited by other articles:


Home page
Psychiatr. Serv.Home page
N. M. Lanouette, D. P. Folsom, A. Sciolla, and D. V. Jeste
Psychotropic Medication Nonadherence Among United States Latinos: A Comprehensive Literature Review
Psychiatr Serv, February 1, 2009; 60(2): 157 - 174.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
I. Lesser, S. Zisook, D. Flores, A. Sciolla, S. Wisniewski, I. Cook, M. Epstein, A. Rosales, C. Gonzalez, M. Trivedi, et al.
Depression Outcomes of Spanish- and English-Speaking Hispanic Outpatients in STAR*D
Psychiatr Serv, November 1, 2008; 59(11): 1273 - 1284.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
M. J. Repetto and J. M. Petitto
Psychopharmacology in HIV-Infected Patients
Psychosom Med, June 1, 2008; 70(5): 585 - 592.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
J. Leserman
Role of Depression, Stress, and Trauma in HIV Disease Progression
Psychosom Med, June 1, 2008; 70(5): 539 - 545.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
M. E. Ohl, B. E. Landon, P. D. Cleary, and J. LeMaster
Medical Clinic Characteristics and Access to Behavioral Health Services for Persons With HIV
Psychiatr Serv, April 1, 2008; 59(4): 400 - 407.
[Abstract] [Full Text] [PDF]


Home page
J Am Board Fam MedHome page
R. B. Goldstein, M. O. Johnson, M. J. Rotheram-Borus, S. B. Kirshenbaum, R. M. Pinto, L. Kittel, W. Pequegnat, J. D. Mickalian, L. S. Weinhardt, J. A. Kelly, et al.
Psychological Distress, Substance Use, and Adjustment among Parents Living with HIV
J Am Board Fam Med, September 1, 2005; 18(5): 362 - 373.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
M. FREEMAN, V. PATEL, P. Y. COLLINS, and J. BERTOLOTE
Integrating mental health in global initiatives for HIV/AIDS
The British Journal of Psychiatry, July 1, 2005; 187(1): 1 - 3.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
J. Leserman, K. Whetten, K. Lowe, D. Stangl, M. S. Swartz, and N. M. Thielman
How Trauma, Recent Stressful Events, and PTSD Affect Functional Health Status and Health Utilization in HIV-Infected Patients in the South
Psychosom Med, May 1, 2005; 67(3): 500 - 507.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
J. Caballero and M. C Nahata
Use of Selective Serotonin-Reuptake Inhibitors in the Treatment of Depression in Adults with HIV
Ann. Pharmacother., January 1, 2005; 39(1): 141 - 145.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2003 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org